Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
A long term follow up study for a comparison of stepwise treatment of asthmatic children with Salmeterol/Fluticasone propionate combination product (Seretide®) and/or Fluticasone propionate (Flixotide®) based on PD20 methacholine and symptoms or based on symptoms only ("Children Asthma Therapy Optimal")
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Any subject who has given informed consent to participate in the CATO study, and has met all the criteria required for randomisation into the clinical study may take part in this follow up study
Under the age of 18 years Subjects and both parent(s)/guardian(s) who have given written informed consent to participate in the study
Subjects from 18 years and older who have given written informed consent to participate in the study
You may not be if
Experienced an acute asthma exacerbation requiring emergency room treatment within 4 weeks or hospitalisation within 4 weeks of visit 1
Any use of oral/parenteral or depot corticosteroid within 4 weeks of visit 1
Subjects who are pregnant (a pregnancy test can be performed at the investigator's discretion)
Clareo Health | A Long Term Prospective Follow Up Study For The CATO Study (SAS30018/SER9702)
